Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Fusion Machinery Between Macrophages and Cancer Cells to Ameliorate Cancer Desmoplasia

NCT05399719 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05399719
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05399719 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Fusion Machinery Between Macrophages and Cancer Cells to Ameliorate Cancer Desmoplasia
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 25, 2022
Completion date
March 10, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow cells, fusion protein expression